{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:11:35Z","timestamp":1784931095385,"version":"3.55.0"},"reference-count":164,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.3109\/10673220903523524","type":"journal-article","created":{"date-parts":[[2010,1,4]],"date-time":"2010-01-04T16:08:50Z","timestamp":1262621330000},"page":"36-55","source":"Crossref","is-referenced-by-count":16,"title":["The Psychopharmacology Algorithm Project at the Harvard South Shore Program"],"prefix":"10.1097","volume":"18","author":[{"given":"Arash","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Osser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1399-5618.2003.01208.x","article-title":"Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects.","volume":"5","author":"Silverstone","year":"2003","journal-title":"Bipolar Disord"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.biopsych.2007.03.016","article-title":"Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and 11CDASB; comparison with bipolar disorder.","volume":"62","author":"Cannon","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1399-5618.2004.00137.x","article-title":"Bipolar depression: phenomenological overview and clinical characteristics.","volume":"6","author":"Mitchell","year":"2004","journal-title":"Bipolar Disord"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4088\/JCP.v69n0705","article-title":"Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study.","volume":"69","author":"Hegerl","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3928\/0048-5713-19990501-09","article-title":"Algorithms for the pharmacotherapy of acute depression in patients with bipolar disorder.","volume":"29","author":"Dantzler","year":"1999","journal-title":"Psychiatr Ann"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10673220802277904","article-title":"The psychopharmacology algorithm project at the Harvard South Shore program: an update on psychotic depression.","volume":"16","author":"Hamoda","year":"2008","journal-title":"Harv Rev Psychiatry"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004714-199304000-00008","article-title":"A systematic approach to the classification and pharmacotherapy of nonpsychotic major depression and dysthymia.","volume":"13","author":"Osser","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"R11-3-20210129","first-page":"303","article-title":"Algorithms for the pharmacotherapy of depression: part one.","volume":"18","author":"Osser","year":"1998","journal-title":"Dir Psychiatry"},{"key":"R12-3-20210129","first-page":"319","article-title":"Algorithms for the pharmacotherapy of depression: part two.","volume":"18","author":"Osser","year":"1998","journal-title":"Dir Psychiatry"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4088\/JCP.v67n0504","article-title":"Agitated unipolar major depression: prevalence, phenomenology, and outcome.","volume":"67","author":"Maj","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jad.2007.08.003","article-title":"Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk.","volume":"107","author":"ODonovan","year":"2008","journal-title":"J Affect Disord"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/070674370204700202","article-title":"Cades disease and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.","volume":"47","author":"Ghaemi","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1176\/appi.ajp.2007.07121931","article-title":"Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers?","volume":"165","author":"Ghaemi","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1467-8721.2007.00502.x","article-title":"The role of the family in the course and treatment of bipolar disorder.","volume":"16","author":"Miklowitz","year":"2007","journal-title":"Curr Dir Psychol Sci"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archpsyc.64.4.419","article-title":"Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.","volume":"64","author":"Miklowitz","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1176\/appi.ajp.2007.07020311","article-title":"Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.","volume":"164","author":"Miklowitz","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.pra.0000290667.02484.3d","article-title":"Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.","volume":"13","author":"Reilly-Harrington","year":"2007","journal-title":"J Psychiatr Pract"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1176\/appi.ajp.2008.08040488","article-title":"Adjunctive psychotherapy for bipolar disorder: state of the evidence.","volume":"165","author":"Miklowitz","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004714-199312000-00005","article-title":"Treatment of depression in bipolar disorder: new directions for research.","volume":"13","author":"Zornberg","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00124509-200003000-00004","article-title":"The efficacy of ECT in mixed affective states.","volume":"16","author":"Devanand","year":"2000","journal-title":"J ECT"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1399-5618.2001.030208.x","article-title":"ECT in bipolar and unipolar depression: differences in speed of response.","volume":"3","author":"Daly","year":"2001","journal-title":"Bipolar Disord"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4088\/JCP.v62n07a09","article-title":"Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression.","volume":"62","author":"Ciapparelli","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"RU31-3-20210129","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4088\/JCP.v66n0712","article-title":"Predictors for the efficacy of electroconvulsive therapy: chart review of a naturalistic study.","volume":"66","author":"Kho","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R32-3-20210129","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archpsyc.1986.01800040052008","article-title":"Persistent tardive dyskinesia in bipolar patients.","volume":"43","author":"Mukherjee","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-2007-1019628","article-title":"Course of the manic-depressive cycle and changes caused by treatment.","volume":"13","author":"Kukopulos","year":"1980","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"R35-3-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.161.1.169","article-title":"Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients.","volume":"161","author":"Zarate","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4088\/JCP.v66n1106","article-title":"Typical and atypical antipsychotics in bipolar depression.","volume":"66","author":"Gao","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pnpbp.2006.06.014","article-title":"Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.","volume":"31","author":"Brugue","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"RU41-3-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","article-title":"What is a mood stabilizer? An evidence-based response.","volume":"161","author":"Bauer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archpsyc.57.2.187","article-title":"Does lithium treatment still work? Evidence of stable responses over three decades.","volume":"57","author":"Baldessarini","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"RU44-3-20210129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/da.20273","article-title":"Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.","volume":"24","author":"Lepkifker","year":"2007","journal-title":"Depress Anxiety"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.chi.0000194569.70912.a7","article-title":"Open-label lithium for the treatment of adolescents with bipolar depression.","volume":"45","author":"Patel","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/ps.2007.58.1.85","article-title":"Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.","volume":"58","author":"Baldessarini","year":"2007","journal-title":"Psychiatr Serv"},{"key":"R48-3-20210129","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","article-title":"Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.","volume":"162","author":"Cipriani","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-2001-15878","article-title":"Does lithium exert an independent antisuicidal effect?","volume":"34","author":"Aherns","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"R50-3-20210129","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4088\/JCP.v69n0605","article-title":"Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.","volume":"69","author":"Marangell","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R51-3-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopsych.2006.10.027","article-title":"Greater cortical gray matter density in lithium-treated patients with bipolar disorder.","volume":"62","author":"Bearden","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimers disease in elderly patients with bipolar disorder.","volume":"190","author":"Nunes","year":"2007","journal-title":"Br J Psychiatry"},{"key":"R53-3-20210129","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis.","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-3-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1600-0447.2003.00274.x","article-title":"Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.","volume":"109","author":"Cavanagh","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10673229309017072","article-title":"Discontinuation of maintenance treatment in bipolar disorder: risks and implications.","volume":"1","author":"Suppes","year":"1993","journal-title":"Harv Rev Psychiatry"},{"key":"R56-3-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.164.2.149","article-title":"Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.","volume":"164","author":"Goodwin","year":"1994","journal-title":"Br J Psychiatry"},{"key":"R57-3-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4088\/JCP.v57n1001","article-title":"Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders.","volume":"57","author":"Baldessarini","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"R58-3-20210129","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","article-title":"Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.","volume":"158","author":"Nemeroff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R59-3-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-5618.2007.00475.x","article-title":"What is the optimal serum lithium level in the long-term treatment of bipolar disordera review?","volume":"10","author":"Severus","year":"2008","journal-title":"Bipolar Disord"},{"key":"R60-3-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.yic.0000224788.21406.c8","article-title":"Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.","volume":"22","author":"Kleindienst","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R61-3-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00406-005-0574-x","article-title":"Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?","volume":"255","author":"Kleindienst","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R63-3-20210129","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R64-3-20210129","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R65-3-20210129","first-page":"29","article-title":"A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.","volume":"22","author":"Endicott","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R66-3-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4088\/JCP.v67n0304","article-title":"Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.","volume":"67","author":"Hirschfeld","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"suppl 1","key":"R67-3-20210129","first-page":"59","article-title":"A double blind, placebo controlled study with acute and continuation phase of quetiapine and paroxetine in adults with bipolar depression (EMBOLDEN II).","volume":"10","author":"McElroy","year":"2008","journal-title":"Bipolar Disord"},{"key":"R72-3-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death.","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"key":"R73-3-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R74-3-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R75-3-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-1781(97)00082-6","article-title":"An open study of lamotrigine in refractory bipolar depression.","volume":"72","author":"Kusumakar","year":"1997","journal-title":"Psychiatry Res"},{"key":"R76-3-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1176\/ajp.156.7.1019","article-title":"Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.","volume":"156","author":"Calabrese","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R77-3-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/070674370204700808","article-title":"Lamotrigine use in geriatric patients with bipolar depression.","volume":"47","author":"Robillard","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R78-3-20210129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.chi.0000194566.86160.a3","article-title":"An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression.","volume":"45","author":"Chang","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R79-3-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1440-1614.2006.01829.x","article-title":"Successful treatment with lamotrigine in bipolar depression: a study from Turkey.","volume":"40","author":"Savas","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"key":"R80-3-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"R81-3-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomized trials.","volume":"194","author":"Geddes","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R82-3-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R83-3-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R84-3-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00004714-199706000-00008","article-title":"The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.","volume":"17","author":"Sporn","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"R86-3-20210129","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","article-title":"A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.","volume":"65","author":"Goodwin","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R87-3-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4088\/JCP.v65n0210","article-title":"A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R88-3-20210129","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4088\/JCP.v63n1110","article-title":"Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R89-3-20210129","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"key":"R90-3-20210129","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/ajp.2006.163.7.1199","article-title":"Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.","volume":"163","author":"Bowden","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R91-3-20210129","first-page":"46","article-title":"Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.","volume":"8","author":"Gualtieri","year":"2006","journal-title":"MedGenMed"},{"key":"R92-3-20210129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R93-3-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapinefluoxetine combination versus lamotrigine in the treatment of bipolar I depression.","volume":"67","author":"Brown","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R94-3-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4088\/JCP.v67n0514","article-title":"A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.","volume":"67","author":"Corya","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R95-3-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in non-psychotic bipolar I depression.","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R96-3-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10401230600801176","article-title":"Adjunctive aripiprazole in treatment-resistant bipolar depression.","volume":"18","author":"Ketter","year":"2006","journal-title":"Ann Clin Psychiatry"},{"key":"R97-3-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jad.2006.11.025","article-title":"Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.","volume":"101","author":"McElroy","year":"2007","journal-title":"J Affect Disord"},{"key":"R98-3-20210129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jad.2008.01.004","article-title":"A prospective, open-label study of aripiprazole mono- and adjunctive treatment in acute bipolar depression.","volume":"110","author":"Dunn","year":"2008","journal-title":"J Affect Disord"},{"key":"R99-3-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v69n0106","article-title":"Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.","volume":"69","author":"Satajovic","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R100-3-20210129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pnpbp.2006.12.009","article-title":"Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.","volume":"31","author":"Kemp","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R101-3-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1345\/aph.1H294","article-title":"Adjunctive aripiprazole in bipolar I depression.","volume":"41","author":"Sokolski","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R102-3-20210129","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.jcp.0000270092.32286.d1","article-title":"Aripiprazole augmentation for treatment-resistant bipolar depression; sustained remission after 36 months.","volume":"27","author":"Kemp","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R103-3-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/JCP.0b013e31816745de","article-title":"High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes.","volume":"28","author":"Mech","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R104-3-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalproex in the treatment of bipolar depression: a placebo-controlled study.","volume":"85","author":"Davis","year":"2005","journal-title":"J Affect Disord"},{"key":"R105-3-20210129","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4088\/JCP.v68n1203","article-title":"Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study.","volume":"68","author":"Ghaemi","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"RU106-3-20210129","first-page":"1001","article-title":"Clinical management guidelines for obstetrician-gynecologists number 92, April 2008. Use of psychiatric medications during pregnancy and lactation.","volume":"111","author":"American College of Obstetrics and Gynecology Practice","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R107-3-20210129","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"R108-3-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/ajp.143.1.29","article-title":"Antidepressant effects of carbamazepine.","volume":"143","author":"Post","year":"1986","journal-title":"Am J Psychiatry"},{"key":"R109-3-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-0327(02)00407-X","article-title":"Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.","volume":"79","author":"Benedetti","year":"2004","journal-title":"J Affect Disord"},{"key":"R110-3-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145708008596","article-title":"A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.","volume":"11","author":"Vieta","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R111-3-20210129","first-page":"suppl","article-title":"Why physicians do not follow some guidelines and algorithms.","volume":"21","author":"Osser","year":"2009","journal-title":"Behav Health Trends"},{"key":"R112-3-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.","volume":"70","author":"Van Der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R113-3-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0165-0327(00)00279-2","article-title":"Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.","volume":"65","author":"Ghaemi","year":"2001","journal-title":"J Affect Disord"},{"key":"R114-3-20210129","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","article-title":"Maintenance efficacy of divalproex in the prevention of bipolar depression.","volume":"28","author":"Gyulai","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R115-3-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).","volume":"109","author":"Vieta","year":"2008","journal-title":"J Affect Disord"},{"key":"R116-3-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Paulsson B; Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127).","volume":"166","author":"Suppes","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R117-3-20210129","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression.","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"R118-3-20210129","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.","volume":"163","author":"Leverich","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R119-3-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0447.2008.01233.x","article-title":"Antidepressants in bipolar depression.","volume":"118","author":"Vieta","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R120-3-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0447.2008.01257.x","article-title":"Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.","volume":"118","author":"Ghaemi","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R121-3-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.2008.01237.x","article-title":"Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.","volume":"118","author":"Licht","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R122-3-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R123-3-20210129","first-page":"391","article-title":"A double-blind trial of bupropion versus desipramine for bipolar depression.","volume":"55","author":"Sachs","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R124-3-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1034\/j.1600-0447.2001.00240.x","article-title":"Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial.","volume":"104","author":"Silverstone","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"R125-3-20210129","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.148.7.910","article-title":"Tranylcypromine versus imipramine in anergic bipolar depression.","volume":"148","author":"Himmelhoch","year":"1991","journal-title":"Am J Psychiatry"},{"key":"R126-3-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00004714-199102000-00008","article-title":"Fluoxetine treatment of bipolar II depression.","volume":"11","author":"Simpson","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"R127-3-20210129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00004714-199812000-00003","article-title":"Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.","volume":"18","author":"Amsterdam","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R128-3-20210129","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4088\/JCP.v62n1212","article-title":"Citalopram as adjunctive therapy in bipolar depression.","volume":"62","author":"Kupfer","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R129-3-20210129","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v63n0607","article-title":"A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.","volume":"63","author":"Vieta","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R130-3-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1399-5618.2003.00083.x","article-title":"Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression-low manic switch rate.","volume":"6","author":"Amsterdam","year":"2004","journal-title":"Bipolar Disord"},{"key":"R131-3-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4088\/JCP.v67n0115","article-title":"An open trial of adjunctive escitalopram in bipolar depression.","volume":"67","author":"Fonseca","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R132-3-20210129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.","volume":"189","author":"Post","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R133-3-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004850-198910000-00006","article-title":"A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder.","volume":"4","author":"Cohn","year":"1989","journal-title":"Int Clin Psychopharmacol"},{"key":"R134-3-20210129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00004714-199810000-00010","article-title":"Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.","volume":"18","author":"Amsterdam","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R135-3-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0165-0327(99)00149-4","article-title":"Venlafaxine monotherapy in women with bipolar II and unipolar major depression.","volume":"59","author":"Amsterdam","year":"2000","journal-title":"J Affect Disord"},{"key":"R136-3-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(99)00041-5","article-title":"A double-blind study comparing idazoxan and bupropion in bipolar depressed patients.","volume":"56","author":"Grossman","year":"1999","journal-title":"J Affect Disord"},{"key":"R137-3-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1399-5618.2002.01189.x","article-title":"Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.","volume":"4","author":"McIntyre","year":"2002","journal-title":"Bipolar Disord"},{"key":"R138-3-20210129","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R139-3-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1176\/appi.ajp.161.1.163","article-title":"Antidepressant treatment in bipolar versus unipolar depression.","volume":"161","author":"Ghaemi","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R140-3-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1176\/appi.ajp.163.2.313","article-title":"Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.","volume":"163","author":"Altshuler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R141-3-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0010-440X(97)90088-2","article-title":"Differential features between bipolar I and bipolar II disorder.","volume":"38","author":"Vieta","year":"1997","journal-title":"Compr Psychiatry"},{"key":"R142-3-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2006.01.024","article-title":"SSRIs as mood stabilizers for bipolar II disorder? A proof of concept study.","volume":"92","author":"Parker","year":"2006","journal-title":"J Affect Disord"},{"key":"R143-3-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b013e318166c4e6","article-title":"Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.","volume":"28","author":"Amsterdam","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R145-3-20210129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1034\/j.1600-0447.2002.01116.x","article-title":"Previous mood state predicts response and switch rates in patients with bipolar depression.","volume":"105","author":"MacQueen","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"R146-3-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","article-title":"Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.","volume":"166","author":"Frye","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R147-3-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4088\/JCP.v59n0706","article-title":"Bipolar depression and antidepressant-induced mania: a naturalistic study.","volume":"59","author":"Boerlin","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R148-3-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1399-5618.2003.00067.x","article-title":"Antidepressant-induced mania: an overview of current controversies.","volume":"5","author":"Goldberg","year":"2003","journal-title":"Bipolar Disord"},{"key":"R149-3-20210129","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4088\/JCP.v63n0907","article-title":"The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study.","volume":"63","author":"Goldberg","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R150-3-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0447.2007.00993.x","article-title":"Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study.","volume":"115","author":"Nolen","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R152-3-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disord"},{"key":"R153-3-20210129","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4088\/JCP.v62n0807","article-title":"The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk of relapse of bipolar depression: a retrospective chart review.","volume":"62","author":"Altshuler","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"RU154-3-20210129","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.160.7.1252","article-title":"Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.","volume":"160","author":"Altshuler","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R155-3-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.08m04191","article-title":"Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.","volume":"70","author":"Altshuler","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R156-3-20210129","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","article-title":"A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R157-3-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","article-title":"Rapid-cycling bipolar disorder: effects of long-term treatments.","volume":"108","author":"Tondo","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"R158-3-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.","volume":"61","author":"Calabrese","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R159-3-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/ajp.145.2.179","article-title":"Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients.","volume":"145","author":"Wehr","year":"1988","journal-title":"Am J Psychiatry"},{"key":"R160-3-20210129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-5618.2007.00479.x","article-title":"Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.","volume":"9","author":"Vieta","year":"2007","journal-title":"Bipolar Disord"},{"key":"R161-3-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-0327(02)00334-8","article-title":"Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.","volume":"73","author":"Sanger","year":"2003","journal-title":"J Affect Disord"},{"key":"R162-3-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder.","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol Psychiatry"},{"key":"R163-3-20210129","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJMct075234","article-title":"Electroconvulsive therapy for depression.","volume":"357","author":"Lisanby","year":"2007","journal-title":"N Engl J Med"},{"key":"R164-3-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.155.1.22","article-title":"Use of ECT for the inpatient treatment of recurrent major depression.","volume":"155","author":"Olfson","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R165-3-20210129","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.","volume":"156","author":"Suppes","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R166-3-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00406-004-0528-8","article-title":"Low doses of clozapine may stabilize treatment-resistant bipolar patients.","volume":"255","author":"Fehr","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R167-3-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4088\/JCP.v64n0416","article-title":"Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.","volume":"64","author":"Ciapparelli","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R168-3-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4088\/JCP.v67n0318","article-title":"The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders.","volume":"67","author":"Chang","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R169-3-20210129","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/ps.49.8.1029","article-title":"Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder.","volume":"49","author":"Reid","year":"1998","journal-title":"Psychiatr Serv"},{"key":"RU170-3-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"RU171-3-20210129","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4088\/JCP.v66n0418","article-title":"Clozapine diminishes suicidal behavior: a retrospective evaluation of clinical records.","volume":"66","author":"Modestin","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R172-3-20210129","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","article-title":"A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.","volume":"164","author":"Frye","year":"2007","journal-title":"Am J Psychiatry"},{"key":"RU173-3-20210129","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/appi.ajp.2007.07050749","article-title":"Modafinil add-on in the treatment of bipolar depression.","volume":"164","author":"Belmaker","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R174-3-20210129","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"R175-3-20210129","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.","volume":"60","author":"Keck","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R176-3-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.","volume":"188","author":"Frangou","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R177-3-20210129","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","article-title":"Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.","volume":"161","author":"Goldberg","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R178-3-20210129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2004.03.013","article-title":"Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.","volume":"56","author":"Zarate","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R179-3-20210129","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","article-title":"Pramipexole in psychiatry: a systematic review of the literature.","volume":"68","author":"Aiken","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R180-3-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.02.012","article-title":"Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review.","volume":"110","author":"Daban","year":"2008","journal-title":"J Affect Disord"},{"key":"R181-3-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2005.01.004","article-title":"Treatment guidelines for bipolar disorder: a critical review.","volume":"86","author":"Fountoulakis","year":"2005","journal-title":"J Affect Disord"},{"key":"RU183-3-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/15622970209150612","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression.","volume":"3","author":"Grunze","year":"2002","journal-title":"World J Biol Psychiatry"},{"key":"RU184-3-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.","volume":"17","year":"2003","journal-title":"J Psychopharmacol"},{"key":"RU185-3-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2008.03.003","article-title":"ECNP consensus meeting. Bipolar depression. Nice, March 2007.","volume":"18","author":"Goodwin","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"RU186-3-20210129","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4088\/JCP.v69n1014","article-title":"International Consensus Group on the evidence-based pharmacological treatment of bipolar I and II depression.","volume":"69","author":"Kaspar","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R187-3-20210129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jama.2009.195","article-title":"Promoting more conservative prescribing.","volume":"301","author":"Schiff","year":"2009","journal-title":"JAMA"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00023727-201001000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T10:17:55Z","timestamp":1685355475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201001000-00003"}},"subtitle":["An Update on Bipolar Depression"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.3109\/10673220903523524","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}